Skip to main content
Log in

Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice

  • Original Article
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10–14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Abedon ST (2017) Commentary: communication between viruses guides lysis-lysogeny decisions. Front Microbiol 8:983

  • Abedon ST, Thomas AC (2010) Phage Therapy Pharmacology. Curr Pharm Biotechnol 11:28–47

    CAS  PubMed  Google Scholar 

  • Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1:66–85

    PubMed  PubMed Central  Google Scholar 

  • Alemayehu D, Casey PG, McAuliffe O et al (2012) Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 3:00029–00012

    Google Scholar 

  • Anderson TF (1949) Bacteriophages. Annu Rev Microbiol 4:21–34

    Google Scholar 

  • Azam H, Tanji Y (2019) Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy. Appl Microbiol Biotechnol 103:4279–4289

    CAS  PubMed  Google Scholar 

  • Basanisi M, LaBella G, Nobili G, Franconieri I, Salandra G (2017) Genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolated from milk and dairy products in South Italy. Food Microbiol 62:141–146

    CAS  PubMed  Google Scholar 

  • Breyne K, Honaker R, Hobbs Z, Richter M, Żaczek M, Spangler T, Steenbrugge J, Lu R, Kinkhabwala A, Marchon B (2017) Efficacy and safety of a bovine-associated Staphylococcus aureus phage cocktail in a murine model of mastitis. Front Microbiol 8:1–27

    Google Scholar 

  • Brouillette E, Malouin F (2005) The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7(3):560–568

    PubMed  Google Scholar 

  • Brüssow H (2005) Phage therapy:the Escherichia coli experience. Microbiology 151:2133–2140

    PubMed  Google Scholar 

  • Bryan D, Elshibiny A, Hobbs Z, Porter J, Kutter E (2016) Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol 7:11–29

    Google Scholar 

  • Cao ZH, Zhang JC, Niu YD et al (2015) Isolation and characterization of a “phiKMV-like” bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia. PLoS One 10(l):0116571

    Google Scholar 

  • Carlton RM (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 47(5):267–274

  • Chandler R (1970) Experimental bacterial mastitis in the mouse. J Med Microbiol 3(2):273–282

    CAS  PubMed  Google Scholar 

  • Donlan R M (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17(2):0–72

    CAS  PubMed  Google Scholar 

  • Doss J, Culbertson K, Hahn D, Camacho J, Barekzi N (2017) A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses 9:50

    PubMed Central  Google Scholar 

  • Duarte VS, Dias R, Kropinski A, Campanaro S, Treu L, Siqueira C, Vieira M, Paes IS, Santana G, Martins F, Crispim J, Xavier A, Ferro C, Vidigal P, Silva C, Paula S (2018) Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows. Sci Rep 8:6845–6857

    Google Scholar 

  • European Food Safety Authority (2009) Scientific report of EFSA prepared by the Animal Health and Animal Welfare Unit (AHAW) on the effect of farming systems on dairy cow welfare and disease. Annex EFSA J 284:1143

    Google Scholar 

  • Gomes F, Henriques M (2016) Control of bovine mastitis: old and recent therapeutic approaches. Curr Microbiol 72:377–382. https://doi.org/10.1007/s00284-015-0958-8

    Article  CAS  PubMed  Google Scholar 

  • Haran K, Godden S, Boxrud D, Jawahir S, Bender J, Sreevatsan S (2012) Prevalence and characterization of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, isolated from bulk tank milk from Minnesota dairy farms. J Clin Microbiol 50:688–695

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hermoso JA, Garcia JL, Garcia P (2007) Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 10:461–472. https://doi.org/10.1016/j.mib.2007.08.002

    Article  CAS  PubMed  Google Scholar 

  • Hertl J, Gröhn Y, Leach J et al (2010) Effects of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on the probability of conception in New York State Holstein dairy cows. J Dairy Sci 93:1551–1560

    CAS  PubMed  Google Scholar 

  • Iwano H, Inoue Y, Takasago T et al (2018) Bacteriophage φA012 has a broad host range against Staphylococcus aureus and effective lytic capacity in a mouse mastitis model. Biology 7:1–13

    Google Scholar 

  • Jamali H, Barkema HW, Jacques M, Lavallée-Bourget EM, Malouin F, Saini V, Stryhn H, Dufour S (2018) Invited review: incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows. J Dairy Sci 101(6):4729–4746

    CAS  PubMed  Google Scholar 

  • Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, Soete O, François P, Teodorescu S, Verween G, Verbeken G, Daniel D, Pirnay J (2017) Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit Care 21:129–130

    PubMed  PubMed Central  Google Scholar 

  • Kawa Z, Skrobek G, Maciejewska B, Delattre A, Lavigne R (2012) Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699–722

    Google Scholar 

  • Kim M, Ryu S (2011) Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli. Appl Environ Microbiol 77:2042–2050

    CAS  PubMed  PubMed Central  Google Scholar 

  • Koen B, Ryan W, Zachary H et al (2017) Efficacy and safety of a bovine-associated Staphylococcus aureus phage cocktail in a murine model of mastitis. Front Microbiol 8(11):1–11

    Google Scholar 

  • Kumaran D, Taha M, Yi Q et al (2018) Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms. Front Microbiol 9(2):1–11

    Google Scholar 

  • Kutter E, De VD, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11(1):69–86

    CAS  PubMed  Google Scholar 

  • Labrie S, Samson J, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327

    CAS  PubMed  Google Scholar 

  • Leaver SK, Evans TW (2007) Acute respiratory distress syndrome. BMJ 335:389–394. https://doi.org/10.1136/bmj.39293.624699.AD

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lenski RE, Levin BR (1985) Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. Am Nat 125:585–602

    Google Scholar 

  • Letarov A, Kulikov E (2010) The bacteriophages in human and animal body associated microbial communities. J Appl Microbiol 107(1):1–13

    CAS  PubMed  Google Scholar 

  • Li Y (2014) Experimental study of Staphylococcus aureus lytic bacteriophage in the treatment of mastitis. Jilin University

  • Li Z, Li X, Zhang J, Wang X, Wang L, Cao Z, Xu Y (2016) Use of phages to control Vibrio splendidus infection in the juvenile sea cucumber Apostichopus japonicus. Fish Shellfish Immunol 54:302–311

    CAS  PubMed  Google Scholar 

  • Liu H, Niu YD, Li J, Stanford K, McAllister TA (2013) In-vitro efficacy of bacteriophages T5, T4, T1 and O1 against E. coli O157:H7. Joint Canadian Society of Animal Science and Canadian Meat Science Association Congress. Banff Canada

  • Liu H, Li S, Meng L, Dong L, Zhao S, Lan X, Wang J, Zheng N (2017) Prevalence, antimicrobial susceptibility, and molecular characterization of Staphylococcus aureus isolated from dairy herds in northern China. J Dairy Sci 100:8796–8803

    CAS  PubMed  Google Scholar 

  • Loessner MJ (2005) Bacteriophage endolysins-current state of research and applications. Curr Opin Biotechnol 8(4):480–487

    CAS  Google Scholar 

  • MacNeal WJ, Frisbee FC (1936) One hundred patients with Staphylococcus septicemia receiving bacteriophage service. Am J Med Sci 191:179–195

    Google Scholar 

  • Maskrey BH, Megson IL, Whitfield PD, Rossi AG (2011) Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 31:1001–1006. https://doi.org/10.1161/ATVBAHA.110.213850

    CAS  PubMed  Google Scholar 

  • Michael CA, Dominey-Howes D, Labbate M (2014) The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health 2:145. https://doi.org/10.3389/fpubh.2014.00145

    Article  PubMed  PubMed Central  Google Scholar 

  • Międzybrodzki R, Fortuna W, Weber-Dąbrowska B, Górski A (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med 9:303–312

    PubMed  Google Scholar 

  • Misra N, Wines TF, Knopp CL, Hermann R, Bond L, Mitchell B, McGuire MA, Tinker JK (2018) Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis. Vaccine 36:3513–3521

    CAS  PubMed  PubMed Central  Google Scholar 

  • Norrby SR, Nord CE, Finch R (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5:115–119. https://doi.org/10.1016/S1473-3099(05)01283–1

  • Notebaert S, Meyer E (2006) Mouse models to study the pathogenesis and control of bovine mastitis. A review. Vet Q 28:2–13

    CAS  PubMed  Google Scholar 

  • Ogawa M (1998) Acute pancreatitis and cytokines: second attack by septic complication leads to organ failure. Pancreas 16:312–315. https://doi.org/10.1097/00006676-199804000-00017

    Article  CAS  PubMed  Google Scholar 

  • Ouyang P (2009) Expression of human lysozyme-antibacterial peptide fusion protein and its efficacy of treating mouse mastitis. Jilin University

  • Petitclerc D, Lauzon K, Cochu A, Ster C, Diarra MS, Lacasse P (2007) Efficacy of a lactoferrin-penicillin combination to treat {beta}-lactam-resistant Staphylococcus aureus mastitis. J Dairy Sci 90:2778–2787

    CAS  PubMed  Google Scholar 

  • Roches A, Lussert A, Faure M et al (2018) Dairy cows under experimentally-induced Escherichia coli mastitis show T negative emotional states assessed through Qualitative Behaviour Assessment. Appl Anim Behav Sci 206:1–11

    Google Scholar 

  • Schmeck B, Moog K, Zahlten J, van Laak V, N’Guessan PD, Opitz B, Rosseau S, Suttorp N, Hippenstiel S (2006) Streptococcus pneumoniae- induced c-Jun-N-terminal kinase-and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res 7:98

    PubMed  PubMed Central  Google Scholar 

  • Schmelcher M et al (2012) Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol 27:2297–2305

    Google Scholar 

  • Schultz EW (1929) The bacteriophage as a therapeutic agent. Cal West Med 31:5–10

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sender G, Pawlik A, Korwin KA (2017) Current concepts on the impact of coagulase-negative staphylococci causing bovine mastitis as a threat to human and animal health – a review. Anim Sci Paper Rep 35(2):123–135

    CAS  Google Scholar 

  • Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, Li J, Nation RL, George N, Paterson DL (2011) Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo- lactamase. Clin Infect Dis 52:481–484. https://doi.org/10.1093/cid/ciq178

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taghavi M, Mortaz E, Khosravi A, Vahedi G, Folkerts G, Varahram M, Kazempour-Dizaji M, Garssen J, Adcock IM (2018) Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice. J Inflamm-Lond 15:5

    PubMed  PubMed Central  Google Scholar 

  • Tuchscherr L, Buzzola F, Alvarez L et al (2005) Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice. Infect Immun 73:7932–7937

    CAS  PubMed  PubMed Central  Google Scholar 

  • Twort FW (1915) An investigation on the nature of ultra-microscopic viruses. Lancet 189:1241–1243

    Google Scholar 

  • Varela DF, Barboza JE, González J et al (2018) Antibiotic susceptibility of Staphylococcus aureus isolated from subclinical bovine mastitis cases and in vitro efficacy of bacteriophage. Vet Res Commun 42:243–250

    Google Scholar 

  • Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N, Hawk HW (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23:445–451

    CAS  PubMed  Google Scholar 

  • Wright A, Hawkins C, Anggård E, Harper D (2009) A con-trolled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34:349–357

    CAS  PubMed  Google Scholar 

  • Xia F, Li X, Wang B et al (2016) Combination therapy of LysGH15 and apigenin as a new strategy for treating pneumonia caused by Staphylococcus aureus. Appl Environ Microbiol 1(82):87–94

    Google Scholar 

  • Xiao F (2015) Experimental study of Staphylococcus aureus phage lysin LysGH15 in the treatment of mastitis. Jilin University

  • Zandkarimi F, Vanegas J, Fern X, Maier CS, Bobe G (2018) Metabo types with elevated protein and lipid catabolism and inflammation precede clinical mastitis in prepartal transition dairy cows. J Dairy Sci 101(6):5531–5548

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang YP (2017) China’s dairy quality continued to improve the construction of modern dairy industry steadily - China dairy quality report. Infect Immun 14–15

  • Zhang JC, Cao ZH, Li Z, Wang L, Li H, Wu F, Jin LJ, Li XY, Li SY, Xu YP (2015) Effect of bacteriophages on Vibrio alginolyticus infection in the sea cucumber, Apostichopus japonicus (Selenka)[J]. J World Aquacult Soc 46(2):149–158

    CAS  Google Scholar 

Download references

Funding

This work was supported by the National Key R&D Program of China (No. 2018YFD0500600) and the National Public Science and Technology Research Funds Projects of Ocean (Grant No. 201405003).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongping Xu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 15 kb)

ESM 2

(JPG 172 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Geng, H., Zou, W., Zhang, M. et al. Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice. Folia Microbiol 65, 339–351 (2020). https://doi.org/10.1007/s12223-019-00729-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-019-00729-9

Navigation